Global Assisted Reproductive Technology Market Size, Share, and COVID-19 Impact Analysis, By Type (IVF, Artificial Insemination), By End-use (Fertility Clinics & Other Facilities, Hospitals & Other Settings), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030Industry: Healthcare
Global Assisted Reproductive Technology Market Insights Forecasts to 2030
- The Assisted Reproductive Technology market was valued at USD 28.2 billion in 2021.
- The market is growing at a CAGR of 6.35% from 2022 to 2030
- The global Assisted Reproductive Technology market is expected to reach USD 42.5 billion by 2030
- Asia Pacific is expected to grow the fastest during the forecast period
Get more details on this report -
The global Assisted Reproductive Technology market is expected to reach USD 42.5 billion by 2030, at a CAGR of 6.35% during the forecast period 2022 to 2030. Throughout the projected period, factors including increased infertility rates, increasing ART success rates, and rising disposable income in developing nations are anticipated to propel industry expansion.
Intracytoplasmic sperm injection (ICSI), in vitro fertilisation (IVF), cryopreservation of embryos or gametes, usage of fertility drugs, and other ART treatments are examples. Assisted reproductive technology (ART) is the name given to the use of medical procedures to treat infertility (ART). Infertility, as defined by the World Health Organization, is the inability to become pregnant after more than a year without using contraception. Both men and women can be affected by infertility. Fertility treatment is the term used when the procedures are utilised to treat infertility. ART is generally used to treat reproductive endocrinology and infertility. Orders for surrogacy are also affected by ART.
This research report categorizes the market for Assisted Reproductive Technology market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Assisted Reproductive Technology market. Recent market developments and competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the Assisted Reproductive Technology market.
Throughout the forecast period, the market for assisted reproductive technologies is expected to rise significantly due to the rising number of single parents, as well as higher awareness about same-sex unions and ARTs. The same-sex marriage rate has climbed to 32 countries as of 2022, according to the Human Rights Campaign (HRC) Foundation's 2022 update. Some countries are now pursuing legislative or judicial action to further enhance this rate. The demand for ART procedures is anticipated to expand dramatically as a result of the rise in same-sex unions, supporting market expansion. The American Society for Reproductive Medicine and the Society for Assisted Reproductive Technologies (SART), among other organisations, are collaborating to raise awareness of the various infertility treatment options. In the area of culture media for ART, numerous novel sorts of study are also being conducted.
Global Assisted Reproductive Technology Market Report Coverage
|Market Size in 2021:||USD 28.2 Billion|
|Forecast Period 2021-2030 CAGR:||6.35%|
|2030 Value Projection:||USD 42.5 Billion|
|Historical Data for:||2017-2020|
|No. of Pages:||199|
|Tables, Charts & Figures:||115|
|Segments covered:||By Type, By End-use, By Region, COVID-19 Impact Analysis|
|Companies Covered:||Cook Medical Inc., Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.), Genea Biomedx, Merck KGaA (EMD Serono, Inc.), Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., The Cooper Companies, Inc. (CooperSurgical, Inc.), Thermo Fisher Scientific, Inc., Vitrolife AB, Cook Medical Inc., Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.), Genea Biomedx, Merck KGaA (EMD Serono, Inc.), Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., The Cooper Companies, Inc. (CooperSurgical, Inc.), Thermo Fisher Scientific, Inc., Vitrolife AB|
|Growth Drivers:||The demand for ART procedures is anticipated to expand dramatically as a result of the rise in same-sex unions, supporting market expansion.|
|Pitfalls & Challenges:||COVID-19 Empact, Challenge, Future, Growth, & Analysis|
Get more details on this report -
Over the projection period, the assisted reproductive technologies (ART) market will experience slow growth due to rising medical procedure costs, ethical issues, the risk of prematurity associated with ART, and a reduced success rate.
- In 2021, the IVF segment is holding the largest market share over the forecast period.
On the basis of type, the assisted reproductive technology has been segmented into IVF and artificial insemination. The sector is further divided by IVF into four categories into fresh non-donor, frozen non-donor, and fresh donor. In 2021, the frozen non-donor category retained a sizable revenue share. The growth is attributable to the advantages of frozen non-donor IVF over conventional IVF techniques. When a woman is releasing viable eggs while receiving ART for male infertility or a fallopian tube abnormality, the frozen non-donor technique is used.
- In 2021, the fertility clinics & other facilities is dominating the market over the forecast period.
Based on the end use, the global assisted reproductive technology has been segmented into Fertility Clinics & Other Facilities, Hospitals & Other Settings. Among these, the fertility clinics and other facilities is dominating the market over the forecast period. The segment is anticipated to continue growing at the fastest rate, maintaining its position as the market leader during the projection period. The high percentage and quick expansion can be ascribed to an increase in infertility cases and the demand for a specialised setting to carry out ART.
Regional Segment Analysis of the Assisted Reproductive Technology Market
Get more details on this report -
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
Europe is dominating the market with the largest market share over the forecast period.
In 2022, Europe dominated the market and generated the biggest revenue share. The large percentage is ascribed to an increase in the infertility rate, greater knowledge of fertility treatments, developments in technology, and encouraging government programmes. For instance, the European Union has the highest rate of infertility in the world—approximately 25 million people—according to the European Society of Human Reproduction and Embryology. During the projection period, North America is anticipated to experience significant expansion. The growth is linked to the success that people experiencing the treatment are experiencing.
- In January 2021, CooperSurgical purchased Embryo Options, a well-known provider of reproductive clinics' cryo-storage software systems.
The report offers the appropriate analysis of the key organizations/companies involved within the global Assisted Reproductive Technology market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of the Key Companies
- Cook Medical Inc.
- Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
- Genea Biomedx
- Merck KGaA (EMD Serono, Inc.)
- Millendo Therapeutics, Inc.
- Oxford Gene Technology
- Progyny Inc.
- The Cooper Companies, Inc. (CooperSurgical, Inc.)
- Thermo Fisher Scientific, Inc.
- Vitrolife AB
Key Target Audience
- Market Players
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Assisted Reproductive Technology market based on the below-mentioned segments:
Assisted Reproductive Technology Market, By Type
- Artificial Insemination
Assisted Reproductive Technology Market, By End User
- Fertility Clinics & Other Facilities
- Hospitals & Other Settings
Assisted Reproductive Technology Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Need help to buy this report?